In the fast-paced world of technological innovation, Large Language Models (LLMs) have emerged as a game-changer, sparking both enthusiasm and trepidation worldwide. Their impact becomes particularly significant within regulated industries, such as pharmaceuticals, healthcare, and finance, where precise control over information handling is pivotal. At Merck, a leading entity within the regulated pharmaceutical industry, the need for stringent standards and practices to safely harness, fine-tune, and deploy LLMs for varied applications becomes all the more crucial.
This insightful presentation aims to address three core aspects:
It will guide you through the fascinating journey of LLM evolution, introducing state-of-the-art practices and common methodologies for their utilization, all within the scope and constraints of regulated industries.
We’ll provide an in-depth exploration into the well-defined standards and practices implemented within Merck. These measures enable data scientists to leverage the power of LLMs securely, ensuring compliance with the regulatory norms that govern such industries.
An intriguing sneak peek into the future is offered, with an evolutionary roadmap of LLMs, including how these models could further shape and influence the workings of regulated industries.
Join us on this enlightening journey, navigating the captivating world of LLMs, their application within the regulated framework of Merck, and a forward-looking perspective on the transformative potential that awaits.
